BotVax B (Canada)This page contains information on BotVax B for veterinary use.
The information provided typically includes the following:
- BotVax B Indications
- Warnings and cautions for BotVax B
- Direction and dosage information for BotVax B
BotVax BThis treatment applies to the following species:
Clostridium botulinum Type B Toxoid
Purified botulinum type B toxoid aluminum phosphate adsorbed. Preservative: 0.01% Thimerosal. Contains no more than 1.85 g/L of formaldehyde as inactivating solution.
BotVax B Indications
BotVax® B is for the prevention of equine botulism due to Clostridium botulinum Type B in healthy horses.
DOSAGE: Inject 2.0 mL intramuscularly at monthly intervals for a total of 3 doses. Booster annually with a single 2.0 mL intramuscular dose.
Research has demonstrated that pregnant mares immunized during the third trimester of gestation, with the third dose (booster) given 2-4 weeks before parturition, respond with antibody. This antibody is concentrated in colostrum and results in significant passively acquired antibody in normal sulking foals.
ADMINISTRATION: Inject intramuscularly using aseptic technique. Shake well before use.
CAUTIONS: Transitory local reactions at the injection site such as heat and minor swelling may occur. Anaphylactoid reactions may occur. Epinephrine is antidotal. Store at 2°-7°C (35°-45°F). Do not freeze. Use the entire contents when opened. Do not vaccinate food producing animals within 21 days of slaughter.
FOR VETERINARY USE ONLY
U.S. Vet. Lic. No. 302
Neogen Corporation, Lansing, MI 48912
10 mL - 5 Doses
NAC No.: 12210013
1040 FOUNTAIN STREET NORTH, UNIT #6, CAMBRIDGE, ON, N3E 1A3
|Every effort has been made to ensure the accuracy of the BotVax B information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2014-05-28